Bicalutamide and feminizing hormone therapy
Bicalutamide for Transgender Women, is an anti-androgen medication, meaning it blocks the effects of androgenic hormones such as testosterone and dihydrotestosterone (DHT) at the tissue level. A key distinction is that bicalutamide does not lower testosterone levels directly—instead, it prevents testosterone from binding to androgen receptors.
In fact, testosterone levels may initially rise after starting bicalutamide. This is expected and not concerning. Over time, testosterone levels often decline, especially when estrogen and progesterone are used alongside bicalutamide as part of a feminizing hormone regimen.
Many individuals exploring bicalutamide for transgender woman may find it beneficial as part of their transition process.
At HEALOR® in Las Vegas, NV, double board-certified physician Dr. Raj Singh provides individualized, lab-guided care for patients seeking transgender hormone therapy.
Traditional and Off-Label Uses of Bicalutamide
Bicalutamide is FDA-approved for prostate cancer treatment. However, it is also used off-label for:
- Puberty suppression
- Feminization therapy in transgender women
- Androgenic alopecia (hair loss) in females
- Acne reduction
👉 This article focuses specifically on bicalutamide use in transgender females as part of gender-affirming care.
For a broader overview of hormone-based transition care, visit:
Transgender Hormone Therapy in Las Vegas
How Bicalutamide Compares to Other Anti-Androgens
Other commonly prescribed anti-androgens include spironolactone (Aldactone) and cyproterone acetate. However:
- Spironolactone is weaker than bicalutamide
- Cyproterone acetate is not available in the United States
One advantage of bicalutamide for transgender woman is that it promotes aromatization of testosterone into estrogen, which may enhance feminizing effects—particularly breast development.
Small studies suggest greater breast growth with bicalutamide compared to spironolactone or cyproterone. One proposed mechanism is that spironolactone may cause early breast bud maturation, potentially limiting long-term growth, whereas bicalutamide allows for more gradual development.
Breast Development and Feminization Benefits
Key Benefits of Bicalutamide in Transgender Women
- Improved breast development compared to spironolactone
- Reduced acne
- Reduced facial and body hair growth
- Strong anti-androgen effect without lowering testosterone abruptly
Because feminization outcomes vary, treatment is always personalized. Learn what to expect from therapy here:
👉 What to Expect From Transgender Hormone Therapy
Duration of Action and Dosing Convenience
Bicalutamide has a long half-life of approximately 6 days, meaning it stays active in the body for several days.
- Typical dosing: 50 mg twice weekly
- Higher doses increase the risk of liver toxicity and should be avoided
By comparison, spironolactone has a half-life of only 2 hours, requiring daily dosing.
Safety Considerations and Contraindications
Use bicalutamide with caution or avoid if you:
- Have liver disease
- Consume alcohol heavily
- Are over the age of 35 (requires closer monitoring)
Animal studies suggest bicalutamide may reduce vitamin C and glutathione levels, which could theoretically increase liver risk. While supplementation may be considered, there is no definitive clinical data supporting this strategy.
Required Lab Monitoring
Because liver toxicity is the most serious risk, careful monitoring is mandatory.
Recommended testing:
- Liver function panel 2–4 weeks after starting therapy
- Immediate discontinuation if symptoms such as jaundice occur
Patients are advised to avoid alcohol and avoid hepatotoxic medications, including acetaminophen (Tylenol).
Lab-guided hormone therapy is a core principle of care at HEALOR®. Learn more about our approach:
👉 Bioidentical & Hormone Therapy Services
Summary: Is Bicalutamide Right for You?
bicalutamide for transgender woman is a powerful and effective anti-androgen for transgender feminization—particularly when breast development is a top priority. However, liver safety is critical, and therapy must be supervised by an experienced physician with regular lab monitoring.
If you’re considering feminizing hormone therapy or exploring bicalutamide for transgender woman, professional guidance matters.
📞 Contact HEALOR® to schedule a confidential consultation in Las Vegas, NV.
